First published online
August 17, 2007, 10.2967/jnumed.107.041129
Diagnosis of Diffuse and Localized Arrhythmogenic Right Ventricular Dysplasia by Gated Blood-Pool SPECT
Denis Mariano-Goulart1,
Laurent Déchaux1,
François Rouzet2,
Eric Barbotte3,
Charles Caderas de Kerleau1,
Michel Rossi1 and
Dominique Le Guludec2
1 Department of Nuclear Medicine, Lapeyronie University Hospital, Montpellier, France; 2 Department of Nuclear Medicine, Bichat University Hospital, Paris, France; and 3 Department of Statistics and Epidemiology, Lapeyronie University Hospital, Montpellier, France

View larger version (15K):
[in this window]
[in a new window]
|
FIGURE 1. Illustration of deformation of the analytic model of time–activity curve M(t) with polynomial function Q(t) to fit acquired noisy data (red dots) and produce 3-dimensional parametric image of local TES.
|
|

View larger version (47K):
[in this window]
[in a new window]
|
FIGURE 2. Local EF (top 2 rows) and local TES (bottom 2 rows) assessed for control subject. First 2 columns concern RV, and last 2 columns concern left ventricle. LEF and REF = mean ± SD of left and right ventricular EF, respectively; L-SD-TES and R-SD-TES = -TES measured for left ventricle and RV, respectively.
|
|

View larger version (50K):
[in this window]
[in a new window]
|
FIGURE 3. Local EF (top 2 rows) and local TES (bottom 2 rows) assessed for patient with localized ARVD. First 2 columns concern RV, and last 2 columns concern left ventricle. LEF and REF = mean ± SD of left and right ventricular EF, respectively; L-SD-TES and R-SD-TES = -TES measured for left ventricle and RV, respectively.
|
|

View larger version (53K):
[in this window]
[in a new window]
|
FIGURE 4. Local EF (top 2 rows) and local TES (bottom 2 rows) assessed for patient with diffuse ARVD. First 2 columns concern RV, and last 2 columns concern left ventricle. LEF and REF = mean ± SD of left and right ventricular EF, respectively; L-SD-TES and R-SD-TES = -TES measured for left ventricle and RV, respectively.
|
|
Copyright © 2007 by the Society of Nuclear Medicine.